相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing
Srinivas R. Viswanathan et al.
CELL (2018)
The Role of Circulating Tumor DNA in Renal Cell Carcinoma
Paulo G. Bergerot et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)
Copy number signatures and mutational processes in ovarian carcinoma
Geoff Macintyre et al.
NATURE GENETICS (2018)
Copy-number analysis identified new prognostic marker in acute myeloid leukemia
O. Nibourel et al.
LEUKEMIA (2017)
The CAPRA Score at 10 Years: Contemporary Perspectives and Analysis of Supporting Studies
Jonathan S. Brajtbord et al.
EUROPEAN UROLOGY (2017)
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
Tracking the Evolution of Non-Small-Cell Lung Cancer
M. Jamal-Hanjani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data
Niedzica Camacho et al.
PLOS GENETICS (2017)
Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children's Oncology Group report
Marijana Vujkovic et al.
BLOOD (2017)
Implementing Genome-Driven Oncology
David M. Hyman et al.
CELL (2017)
Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making
Wassim Abida et al.
JCO PRECISION ONCOLOGY (2017)
Non-invasive detection of genome-wide somatic copy number alterations by liquid biopsies
Ellen Heitzer et al.
MOLECULAR ONCOLOGY (2016)
Revisiting tumour aneuploidy - the place of ploidy assessment in the molecular era
Havard E. Danielsen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers
H. Wang et al.
ONCOGENE (2016)
Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy
L. Liang et al.
ONCOGENE (2016)
Coordinated Tumor Suppression by Chromosome 8p
Darjus F. Tschaharganeh et al.
CANCER CELL (2016)
Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement
Ronald C. Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Deletions linked to TP53 loss drive cancer through p53-independent mechanisms
Yu Liu et al.
NATURE (2016)
Active surveillance for prostate cancer: current evidence and contemporary state of practice
Jeffrey J. Tosoian et al.
NATURE REVIEWS UROLOGY (2016)
FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing
Ronglai Shen et al.
NUCLEIC ACIDS RESEARCH (2016)
High burden of copy number alterations and c-MYC amplification in prostate cancer from BRCA2 germline mutation carriers
E. Castro et al.
ANNALS OF ONCOLOGY (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Giovanni Ciriello et al.
CELL (2015)
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology
Donavan T. Cheng et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer
Shu Xia et al.
ONCOTARGET (2015)
Integration and comparison of different genomic data for outcome prediction in cancer
Hugo Gomez-Rueda et al.
BIODATA MINING (2015)
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Nishant Agrawal et al.
CELL (2014)
Copy number alteration burden predicts prostate cancer relapse
Haley Hieronymus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
Julia L. Williams et al.
CANCER GENETICS (2014)
Unraveling the clonal hierarchy of somatic genomic aberrations
Davide Prandi et al.
GENOME BIOLOGY (2014)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Pan-cancer patterns of somatic copy number alteration
Travis I. Zack et al.
NATURE GENETICS (2013)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Absolute quantification of somatic DNA alterations in human cancer
Scott L. Carter et al.
NATURE BIOTECHNOLOGY (2012)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim et al.
NATURE (2010)
Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis
A. Walther et al.
GUT (2008)
Long-term outcome among men with conservatively treated localised prostate cancer
J. Cuzick et al.
BRITISH JOURNAL OF CANCER (2006)
The University of California, San Francisco cancer of the prostate risk assessment score: A straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy
MR Cooperberg et al.
JOURNAL OF UROLOGY (2005)